상세검색
최근 검색어 전체 삭제
다국어입력
즐겨찾기0
약학회지 제67권 제5호(2023년).jpg
KCI등재 학술저널

디지털 치료기기의 특성 및 사용 평가

Characteristics and User Evaluation of Digital Therapeutics: An Exploratory Study Focusing on reSET®, reSET-O®, and Somryst®

DOI : 10.17480/psk.2023.67.5.285
  • 95

Digital therapeutics (DTx) are defined as high-quality software designed to prevent, manage, and treat medical disorders or diseases by providing evidence-based therapeutic interventions. In this study, an investigation was conducted to examine the characteristics of DTx, including their methods, safety-related data, and user evaluations of reSET®, reSET-O®, and Somryst®. These DTx solutions have recently obtained the first FDA approval and the first insurance code registration by government. However, there are limitations in terms of the quantitative scale of patient feedback evaluations and concerns about accuracy, as indicated by research findings. Nevertheless, with the active global development of DTx and the increasing scale of investment, pharmacists need to pay attention to and prepare for this innovative treatment concept.

서 론(Introduction)

방 법(Methods)

결 과(Results)

고 찰(Discussion)

결 론(Conclusion)

감사의 말씀(Acknowledgment)

Conflict of Interest

References

로딩중